| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.37 | 0.03 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |